On the immunogenic properties of retro-inverso peptides. Total retro- inversion of T-cell epitopes causes a loss of binding to MHC II molecules

Molecular Immunology

Volumn 34, Issue 2, 1997, Pages 157-163

  Hervé, Mireille ^a   Maillère, Bernard ^a   Mourier, Gilles ^a   Texier, Catherine ^a   Leroy, Sandrine ^a   Ménez, André ^a  

^a DIF   (France)

Author keywords

hydrogen bonds; I E(d); immunogenicity; MHC II binding; pseudopeptide; retro inverso peptides; T cell epitopes

Indexed keywords

EPITOPE; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; T LYMPHOCYTE RECEPTOR;

ALLERGIC DISEASE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIBODY SPECIFICITY; ARTICLE; BINDING AFFINITY; HYPERSENSITIVITY; IMMUNOGENICITY; MAJOR HISTOCOMPATIBILITY COMPLEX; MOUSE; NONHUMAN; PEPTIDE SYNTHESIS; PRIORITY JOURNAL; PROTEIN BINDING;

AMINO ACID SEQUENCE; ANIMALS; COBRA NEUROTOXINS; DRUG DESIGN; EPITOPES, T-LYMPHOCYTE; FEMALE; HISTOCOMPATIBILITY ANTIGENS CLASS II; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED BALB C; MOLECULAR SEQUENCE DATA; PEPTIDE FRAGMENTS; STRUCTURE-ACTIVITY RELATIONSHIP;

ANIMALIA;

EID: 0342378184     PISSN: 01615890     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0161-5890(97)00004-7     Document Type: Article

References (36)

1. Allen P. M. (1987) Antigen processing at the molecular level. Immun. Today 8, 270-273.
2. Beeson C. and McConnell H. M. (1994) Kinetic intermediates in the reactions between peptides and proteins of major histocompatibility complex class II. Proc. natn. Acad. Sci. U.S.A. 91, 8842-8845.
3. Benkirane N., Friede M., Guichard G., Briand J. P., Van Regenmortel M. H. V. and Muller S. (1993) Antigenicity and immunogenicity of modified synthetic peptides containing D-amino acid residues. J. Biol. Chem. 268, 26279-26285.
4. Benkirane N., Guichard G., Van Regenmortel M. H. V., Briand J. P. and Muller S. (1995) Cross-reactivity of antibodies to retro-inverso peptidomimetics with the parent protein histone H3 and chromatin core particle. J. Biol. Chem. 270, 11921-11926.
5. Bradford A. J., McDonnell J. M., Marini J. C. and Korngold R. (1994) A rationally designed CD4 analogue inhibits experimental allergic encephalomyelitis. Nature 368, 744-746.
6. Briand J. P., Guichard G., Dumortier H. and Muller S. (1995) Retro-inverso peptidomimetics as new immunological probes. J. Biol. Chem. 270, 20686-20691.
7. Buus S., Sette A., Colon S. M., Miles C. and Grey H. M. (1987) The relation between major histocompatibility complex restriction and the capacity of Ia to bind immunogenic peptide. Science 235, 1353-1358.
8. Chorev M. and Goodman M. (1993) A dozen years of retro-inverso peptidomimetics. Ace. Chem. Res. 26, 266-273.
9. Cox J. H., Ivanyi J., Young D. B., Lamb J. R., Syred A. D. and Francis M. J. (1988) Orientation of epitopes influences the immunogenicity of synthetic peptide dimers. Eur. J. Immun. 18, 2015-2019.
10. Dintzis H. M., Symer D. E., Dintzis R. Z., Zawadzke L. E. and Berg J. M. (1993) A comparison of the immunogenicity of a pair of enantiomeric proteins. Proteins 16, 306-308.
11. Fremont D. H., Hendrickson W. A., Marrack P. and Kappler J. (1996) Structures of an MHC class II molecule with covalently bound single peptide. Science 272, 1001-1004.
12. Ghosh P., Amaya M., Mellins E. and Wiley D. C. (1995) The structure of an intermediate in class II MHC maturation: CLIP bound to HLA-DR3. Nature 378, 457-462.
13. Golvano J., Lasarte J. J., Sarobe P., Gullon A., Prieto J. and Borras-Cuesta F. (1990) Polarity of immunogens: implications for vaccine design. Eur. J. Immun. 20, 2363-2366.
14. Guichard G., Benkirane N., Zeder-Lutz G., Van Regenmortel M. H. V., Briand J. P. and Muller S. (1994) Antigenic mimicry of natural L-peptides with retro-inverso-peptidomimetics. Prot: natn. Acad. Sci. U.S.A. 91, 9765-9769.
15. Hammer J., Bono E., Gallazi F., Belunis C., Nagy Z. and Sinigaglia F. (1994) High-affinity binding of short peptides to major histocompatibility complex class II molecules by anchor combinations. J. Exp. Med. 180, 2353-2358.
16. Hill M. C., Liu A., Marshall K. W., Mayer J., Jorgensen B., Yuan B., Cubbon R. M., Nichols E. A., Wicker L. S. and Rothbard J. B. (1994) Exploration of requirements for peptide binding to HLA DRB1*0101 and DRB 1*0401. J. Immun. 152, 2890-2898.
17. Jardetzky T. S., Gorga J. C., Busch R., Rothbard J., Strominger J. L. and Wiley D. C. (1990) Peptide binding to HLA-DR1: a peptide with most residues substituted to alanine retains MHC binding. EMBO J. 9, 1797-1803.
18. Jardetzky T. S., Brown J. H., Gorga J. C., Stern L. J., Urban R. G., Strominger J. L. and Wiley D. C. (1996) Crystallographic analysis of endogenous peptides associated with HLA-DR1 suggests a common, polyproline II-like conformation for bound peptides. Proc. natn. Acad. Sci. U.S.A. 93, 734-738.
19. Jaton J. C. and Sela M. (1968) Role of optical configuration in the immunogenicity and specificity of synthetic antigens derived from multichain polyproline. J. Biol. Chem. 243, 5616-5626.
20. Jorgensen J. L., Reay P. A., Ehrich E. W. and Davis M. M. (1992) Molecular components of T cell recognition. Ann. Rev. Immun. 10, 835-873.
21. King T. P., Wade D., Coscia M. R., Mitchell S., Kochoumian L. and Merrifield B. (1994) Structure-immunogenicity relationship of melittin, its transposed analogues and D-melit-tin. J. Immun. 153, 1124-1131.
22. Leclerc C., Przewlocki G., Schutze M. P. and Chedid L. (1987) A synthetic vaccine constructed by copolymerisation of B and T cell determinant. Eur. J. Immun. 17, 269-273.
23. Maillère B., Cotton J., Mourier G., Léonetti M., Leroy S. and Ménez A. (1993) Role of thiols in the presentation of a snake toxin to murine T cells. J. Immun. 150, 5270-5280.
24. Maillère B., Mourier G., Cotton J., Hervé M., Leroy S. and Ménez A. (1995) Probing immunogenicity by L-Ala and D-amino acids scanning. Mol. Immun. 32, 1073-1080.
25. Maillère B., Mourier G., Hervé M. and Ménez A. (1995) Fine chemical modifications at N- and C- termini enhance peptide presentation to T cells by increasing the lifespan of both free and MHC-complexed peptides. Mol. Immun. 32, 1377-1385.
26. Marshall K. W., Liu A. F., Canales J., Perahia B., Jorgensen B., Gantzos R. D., Aguilar B., Devaux B. and Rothbard J. B. (1994) Role of polymorphic residues in HLA-DR molecules in allele-specific binding of peptide ligands. J. Immun. 152, 4946-4957.
27. Marshall K. W., Wilson K. J., Liang J., Woods A., Zaller D. and Rothbard J. B. (1995) Prediction of peptide affinity to HLA DRB1*0401. J. Immun. 154, 5927-5933.
28. Merrifield R. B., Juvvadi P., Andreu D., Ubach J., Boman A. and Boman H. G. (1995) Retro and retroenantio analogs of ceropin-melitin hybrids. Proc. natn. Acad. Sci. U.S.A. 92, 3449-3453.
29. Muller S., Guichard G., Benkirane N., Brown F., Van Regenmortel M. H. V. and Briand J. P. (1995) Enhanced immunogenicity and cross-reactivity of retro-inverso peptidomimetics of the major antigenic site of foot-and-mouth disease virus. Peptide Res. 8, 138-144.
30. Ruvo M. and Fassina G. (1995) End-group modified retro-inverso isomers of tripeptide oxytocin analogues: binding to neurophysin II and enhancement of its self-association properties. Int. J. Peptide Protein Res. 45, 356-365.
31. Sela M., Mozes E. and Shearer G. M. (1972) Thymus independence of slowly metabolized immunogens. Proc. natn. Acad. Sci. U.S.A. 69, 2696-2700.
32. Sette A., Sidney J., Oseroff C, Del Guercio M. F., Southwood S., Arrhenius T., Powell M. F., Colon S. M., Gaeta F. C. A. and Grey H. M. (1993) HLA-DR4w4 binding motifs illustrate the biochemical basis of degeneracy and specificity in peptide-DR interactions. J. Immun. 151, 3163-3170.
33. Stern L. J., Brown J. H., Jardetzky T. S., Gorga J. C., Urban R. G., Strominger J. L. and Wiley D. C. (1994) Crystal structure of the human class II MHC protein HLA-DR1 complexed with an influenza virus peptide. Nature 368, 215-221.
34. Verdoliva A.. Ruvo M., Cassani G. and Fassina G. (1995) Topological mimicry of cross-reacting enantiomeric peptide antigens. J. Biol. Chern. 270, 30422-30427.
35. Verdoliva A., Ruvo M., Villain M., Cassani G. and Fassina G. (1995) Antigenicity of topochemically related peptides. Biochem. Biophys. Acta 1253, 57-62.
36. Viguier M., Dormair K., Clark B. R. and McConnell H. M. (1990) The invariant chain forms complexes with class II major histocompatibility complex molecules and antigenic peptides in vitro. Proc. natn. Acad. Sci. U.S.A. 87, 7170-7174.